id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OAR-2002-0095-0245,EPA,EPA-HQ-OAR-2002-0095,Technology and Economic Assessment Panel (UNEP) [A-93-39-VII-B-1],Supporting & Related Material,Publication,2023-11-06T05:00:00Z,2023,11,,,2023-11-06T18:57:08Z,,0,0,0900006483d7e782
EPA-HQ-OAR-2002-0095-0243,EPA,EPA-HQ-OAR-2002-0095,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2000: Allocations for Metered-Dose Inhalers and the Space Shuttle and Titan Rockets [A-93-39-VII-A-3],Rule,Final Rule,2022-10-06T04:00:00Z,2022,10,2022-10-06T04:00:00Z,2000-03-28T04:59:59Z,2022-10-06T18:47:51Z,00-4520,0,0,0900006483d7e781
EPA-HQ-OAR-2002-0095-0242,EPA,EPA-HQ-OAR-2002-0095,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2000: Allocations for Metered-Dose Inhalers and the Space Shuttle and Titan Rockets [A-93-39-VII-A-2],Rule,Interim Final Rule,2022-10-06T04:00:00Z,2022,10,2022-10-06T04:00:00Z,2000-02-08T04:59:59Z,2022-10-06T18:39:59Z,00-273,0,0,0900006483d7e780
EPA-HQ-OAR-2002-0095-0241,EPA,EPA-HQ-OAR-2002-0095,Protection of Stratospheric Ozone: Allocation of 2000 Essential Use Allowances [A-93-39-VII-A-1],Proposed Rule,Notice of Proposed Rulemaking (NPRM),2022-10-06T04:00:00Z,2022,10,2022-10-06T04:00:00Z,1999-12-03T04:59:59Z,2022-10-06T18:32:18Z,99-28506,0,0,0900006483d7e77f
EPA-HQ-OAR-2002-0095-0216,EPA,EPA-HQ-OAR-2002-0095,"Letter from Terence Young, Western Farmers Electric Cooperative (WFEC), Anadarko, OK. [A-93-39-XI-H-7]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:42:07Z,,0,0,0900006483d7e6e6
EPA-HQ-OAR-2002-0095-0211,EPA,EPA-HQ-OAR-2002-0095,Data Table: Annex I - Essential Use Nominations For 2002-2004 Authorized by the Thirteenth Meeting of the Parties (in metric tonnes). [A-93-39-XII-A-3],Supporting & Related Material,Data,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:41:10Z,,0,0,0900006483d7e6ec
EPA-HQ-OAR-2002-0095-0227,EPA,EPA-HQ-OAR-2002-0095,"International Pharmaceutical Aerosol Consortium (IPAC), Washington, DC. Request for Nomination of the MDI as an Essential Use. [A-93-39-II-A-4]",Supporting & Related Material,Publication - Copyrighted Materials,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:22Z,,0,0,0900006483d7e6bc
EPA-HQ-OAR-2002-0095-0221,EPA,EPA-HQ-OAR-2002-0095,"J.H. McCord, Jr., Lab Manager, Davis & Floyd, Incorporated [A-93-39-XI-H-2]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:44:01Z,,0,0,0900006483d7e6e1
EPA-HQ-OAR-2002-0095-0214,EPA,EPA-HQ-OAR-2002-0095,"Daniel M. Panek, Director, JLI Environmental Laboratories, Auburn, NY. [A-93-39-XI-H-9]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:41:56Z,,0,0,0900006483d7e6e8
EPA-HQ-OAR-2002-0095-0208,EPA,EPA-HQ-OAR-2002-0095,Letter from E. Allera and T. Halpern of Buchanan Ingersoll to S. Monroe of EPA re: Imminent Change in name of Sidmak Laboratories [A-93-39-XII-A-6],Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:40:28Z,,0,0,0900006483d7e6f0
EPA-HQ-OAR-2002-0095-0235,EPA,EPA-HQ-OAR-2002-0095,"40 CFR Part 82 Protection of Stratospheric Ozone: Allocation of 2000
Essential Use Allowences; Notice of Proposed Rulemaking (64 FR 59141) [A-93-39-X-A-1]",Supporting & Related Material,Publication - Previous/Related FR Notice,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:46:03Z,,0,0,0900006483d7e6db
EPA-HQ-OAR-2002-0095-0238,EPA,EPA-HQ-OAR-2002-0095,"Dr. B.A. Schwetz, Acting Principal Deputy Commissioner, U.S. Food and Drug Administration (FDA) to P. Stolpman, Director, Office of Atmospheric Programs (OAP), Office of Air & Radiation (OAR), USEPA. [A-93-39-XI-A-2]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:46:48Z,,0,0,0900006483d7e6dd
EPA-HQ-OAR-2002-0095-0230,EPA,EPA-HQ-OAR-2002-0095,"K. H. Mody, Director of Operations, Medisol Laboratories, Inc., East Hanover, NJ. [A-93-39-II-A-6]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:42Z,,0,0,0900006483d7e6be
EPA-HQ-OAR-2002-0095-0231,EPA,EPA-HQ-OAR-2002-0095,"Memorandum to William Schrock, USEPA/OAQPS/ESD/OCG, from Thomas Holloway, Midwest Research Institute (MRI) regarding Major and Area Sources in the Cellulose Products Manufacturing Industry EPA Contract No. 68-D6-0012; Task Order No. 0041; ESD No. 97/06 MRI Project No. 4803-41. [A-93-39-II-B-33]",Supporting & Related Material,Memorandum,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:49Z,,0,0,0900006483d7e6c0
EPA-HQ-OAR-2002-0095-0233,EPA,EPA-HQ-OAR-2002-0095,"Memorandum to William Schrock, USEPA/OAQPS/ESD/OCG, from Karen Schmidtke et al., Midwest Research Institute (MRI) regarding Industry Profile of Cellulose Products Manufacturing Facilities in the U.S. EPA Contract No. 68-D6-0012; Task Order No. 0041; ESD No. 97/06 MRI Project No. 4803-41 [A-93-39-II-B-36]",Supporting & Related Material,Memorandum,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:54Z,,0,0,0900006483d7e6c2
EPA-HQ-OAR-2002-0095-0224,EPA,EPA-HQ-OAR-2002-0095,"TEAP Handbook on Essential Use Allowances, Appendix B: Decisions of the Montreal Protocol 2001- Contains the text of Decisions IV/25, XI/15 and XII/2 [A-93-39-XI-A-3]",Supporting & Related Material,Guidance,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:44:37Z,,0,0,0900006483d7e6de
EPA-HQ-OAR-2002-0095-0207,EPA,EPA-HQ-OAR-2002-0095,Protection of Stratospheric Ozone: Allocation of  Essential Use Allowances for Calendar Year 2002; Notice of Proposed Rulemakina [A-93-39-XII-B-1],Supporting & Related Material,Publication - Previous/Related FR Notice,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:40:24Z,,0,0,0900006483d7e6f1
EPA-HQ-OAR-2002-0095-0219,EPA,EPA-HQ-OAR-2002-0095,"D. J. Ivey, President, Environmental Labs & Services, Incorporated, Carrollton, GA [A-93-39-XI-H-4]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:43:54Z,,0,0,0900006483d7e6e3
EPA-HQ-OAR-2002-0095-0218,EPA,EPA-HQ-OAR-2002-0095,"Letter from Kevin Shelburne, Owner, TEG Puerto Rico, Caguas, PR. [A-93-39-XI-H-5]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:42:12Z,,0,0,0900006483d7e6e4
EPA-HQ-OAR-2002-0095-0215,EPA,EPA-HQ-OAR-2002-0095,"Ron Melton, Western Farmers Electric Cooperative (WFEC), Mooreland, OK. [A-93-39-XI-H-8]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:42:00Z,,0,0,0900006483d7e6e7
EPA-HQ-OAR-2002-0095-0234,EPA,EPA-HQ-OAR-2002-0095,"Economic Impact Analysis for the Proposed Miscellaneous Cellulose Manufacturing Industry NESHAP. USEPA, Contract/Grant No. 68-D-99-024, EPA-452-D-00-00-002, May 2000. [A-93-39-II-B-45]",Supporting & Related Material,Publication - USEPA,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:56Z,,0,0,0900006483d7e6c3
EPA-HQ-OAR-2002-0095-0222,EPA,EPA-HQ-OAR-2002-0095,"T.U. Powell, Lab Director, EcoTest Laboratories, Incorporated, North Babylon, NY [A-93-39-XI-H-1]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:44:03Z,,0,0,0900006483d7e6e0
EPA-HQ-OAR-2002-0095-0213,EPA,EPA-HQ-OAR-2002-0095,"Letter to . Lester M. Crawford, Jr, FDA from Brian McLean, EPA requesting  determination on the amount of chlorofluorocarbons (CFCs) for metered-dose inhalers (MDIs) in the year 2003. [A-93-39-XII-A-1]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:41:40Z,,0,0,0900006483d7e6ea
EPA-HQ-OAR-2002-0095-0236,EPA,EPA-HQ-OAR-2002-0095,"Letter to Paul Stolpman, USEPA, Office of Atmospheric Programs, from Jane Henney, M.D., Commissioner, U.S. Food and Drug Administration (FDA), regarding FDA determination on the amounts of chloroflurocarbons (CFCs) necessary for use in medical devices. [A-93-39-VIII-B-4]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:46:06Z,,0,0,0900006483d7e6da
EPA-HQ-OAR-2002-0095-0225,EPA,EPA-HQ-OAR-2002-0095,"Adams Laboratories, Inc. Renewal of the December 27, 1994 Application Seeking an Essential Use Exemption from the Montreal Protocol's CFC Production and Import Phase-Out for 1997. [A-93-39-II-A-2]",Supporting & Related Material,Report,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:09Z,,0,0,0900006483d7e6ba
EPA-HQ-OAR-2002-0095-0217,EPA,EPA-HQ-OAR-2002-0095,"Letter from Chuck Wallgren, President, Pollution Control Services, San Antonio, TX. [A-93-39-XI-H-6]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:42:09Z,,0,0,0900006483d7e6e5
EPA-HQ-OAR-2002-0095-0232,EPA,EPA-HQ-OAR-2002-0095,"Memorandum to William Schrock, USEPA/OAQPS/ESD/OCG, from Karen Schmidtke, Midwest Research Institute (MRI) regarding List of Correspondence with Facilities in the Cellulose Products Manufacturing Industry EPA Contract No. 68-D6-0012; Task Order No. 0041; ESD No. 97/06 MRI Project No. 4803-41 [A-93-39-II-B-34]",Supporting & Related Material,Memorandum,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:51Z,,0,0,0900006483d7e6c1
EPA-HQ-OAR-2002-0095-0228,EPA,EPA-HQ-OAR-2002-0095,"T. C. Coyne, M.D., Vice President, Clinical & Medical Affairs, Medeva Americas, Inc., Fort Worth, TX. [A-93-39-II-A-5]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:27Z,,0,0,0900006483d7e6bd
EPA-HQ-OAR-2002-0095-0220,EPA,EPA-HQ-OAR-2002-0095,"N.B. Dellavalle, President, Dellavalle Laboratory, Incorporated, Fresno, CA [A-93-39-XI-H-3]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:43:59Z,,0,0,0900006483d7e6e2
EPA-HQ-OAR-2002-0095-0209,EPA,EPA-HQ-OAR-2002-0095,Record of EPA meeting with GlaxoSmith Kline. [A-93-39-XII-A-5],Supporting & Related Material,Meeting Materials,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:40:43Z,,0,0,0900006483d7e6ef
EPA-HQ-OAR-2002-0095-0223,EPA,EPA-HQ-OAR-2002-0095,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2002; and Extension of the De Minimus Exemption for Essential Laboratory and Analytical Uses through Calendar Year 2005; Notice of Proposed Rulemaking 66 FR 55145.[A-93-39-XI-A-4],Supporting & Related Material,Publication - Previous/Related FR Notice,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:44:08Z,,0,0,0900006483d7e6df
EPA-HQ-OAR-2002-0095-0212,EPA,EPA-HQ-OAR-2002-0095,"Letter to Brian McLean, EPA from Lester Crawford, FDA with recommendations on the total amounts of CFC necessary to ensure public health. [A-93-39-XII-A-2]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:41:33Z,,0,0,0900006483d7e6eb
EPA-HQ-OAR-2002-0095-0210,EPA,EPA-HQ-OAR-2002-0095,"Letters to Manufacturers from EPA requesting cooperation in determining the amount of
chlorofluorocarbons (CFCs) needed to manufacture metered dose inhalers (MDIs) in the US in the year 2003 [A-93-39-XII-A-4]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:41:05Z,,0,0,0900006483d7e6ee
EPA-HQ-OAR-2002-0095-0229,EPA,EPA-HQ-OAR-2002-0095,"J. J. Sciarra, Ph.D., President and Director of Research and Development,
Sciarra Laboratories, Hicksville, NY [A-93-39-II-A-7]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:41Z,,0,0,0900006483d7e6bf
EPA-HQ-OAR-2002-0095-0226,EPA,EPA-HQ-OAR-2002-0095,"J. F. Doerner, Director Operations, Dura Pharmaceuticals, San Diego, CA. Nomination for Essential Use Exemption. [A-93-39-II-A-3]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:45:15Z,,0,0,0900006483d7e6bb
EPA-HQ-OAR-2002-0095-0237,EPA,EPA-HQ-OAR-2002-0095,"P. Stolpman, Director, Office of Atmospheric Programs (OAP), Office of Air & Radiation (OAR), USEPA to Dr. B.A. Schwertz, Lead Deputy
Commissioner, U.S. Food and Drug Administration (FDA). [A-93-39-XI-A-1]",Supporting & Related Material,Letter,2022-07-21T04:00:00Z,2022,7,,,2022-07-21T15:46:45Z,,0,0,0900006483d7e6dc
EPA-HQ-OAR-2002-0095-0042,EPA,EPA-HQ-OAR-2002-0095,"Nomination request for essential uses of halons - 1993 
[A-93-39-I-1]",Notice,,2022-07-13T04:00:00Z,2022,7,2022-07-13T04:00:00Z,,2022-07-13T17:52:45Z,93-2384,0,0,0900006483d7eb6a
EPA-HQ-OAR-2002-0095-0027,EPA,EPA-HQ-OAR-2002-0095,"C. J. Sciarra, Vice-President, SCIARRA Laboratories, Inc., Hicksville, NY [A-93-39-IX-A-2]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:45:26Z,,0,0,0900006483d7e6c6
EPA-HQ-OAR-2002-0095-0035,EPA,EPA-HQ-OAR-2002-0095,"Minutes of the Meeting with the Food & Drug Administration, Environmental Protection Agency, & 3M Pharmaceuticals on 03-02-00 [A-93-39-VII-E-1]",Supporting & Related Material,Memorandum,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:52Z,,0,0,0900006483d7e6cc
EPA-HQ-OAR-2002-0095-0024,EPA,EPA-HQ-OAR-2002-0095,U. S. nomination withdrawal letter[A-93-39-I-3],Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:45:11Z,,0,0,0900006483d7eb6c
EPA-HQ-OAR-2002-0095-0036,EPA,EPA-HQ-OAR-2002-0095,"C. Dabruzzi, National Account Manager, 3M Pharmaceuticals/ 3MDrug Delivery Systems, Minnesota Mining & Manufacturing Company (3M) [A-93-39-IX-A-8]",Supporting & Related Material,Report,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:57Z,,0,0,0900006483d7e6cb
EPA-HQ-OAR-2002-0095-0034,EPA,EPA-HQ-OAR-2002-0095,"Minutes of the Teleconference with the Food & Drug Administration, Environmental Protection Agency, & Glaxo Wellcome Pharmaceuticals on
04-20-00 [A-93-39-VII-E-2]",Supporting & Related Material,Memorandum,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:49Z,,0,0,0900006483d7e6cd
EPA-HQ-OAR-2002-0095-0031,EPA,EPA-HQ-OAR-2002-0095,"J. E. Henney, M. D., Commissioner, Department of Health & Human Services, Food & Drug Administration, requesting supplemental of their letter on 12-23-99 [A-93-39-VII-H-4]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:33Z,,0,0,0900006483d7e6d3
EPA-HQ-OAR-2002-0095-0020,EPA,EPA-HQ-OAR-2002-0095,Letters requesting information under section 114 of the Clean Air Act from essential use applicants for CFCs [A-93-39-VIII-B-2],Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:08:21Z,,0,0,0900006483d7e6d8
EPA-HQ-OAR-2002-0095-0041,EPA,EPA-HQ-OAR-2002-0095,"J. E. Henney, M.D., Commissioner, Department of Health & Human Services, Food & Drug Administration, requesting supplemental of their letter on 01-21-00 [A-93-39-VII-H-5]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:47:44Z,,0,0,0900006483d7e6d4
EPA-HQ-OAR-2002-0095-0023,EPA,EPA-HQ-OAR-2002-0095,"U. S. nomination letter for essential uses of halons - 1993 
[A-93-39-I-2]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:45:06Z,,0,0,0900006483d7eb6b
EPA-HQ-OAR-2002-0095-0029,EPA,EPA-HQ-OAR-2002-0095,"J. A. Nusser, Senior Director, Environmental Compliance and Projects, Schering -Plough Corporation, Kenilworth, NJ [A-93-39-IX-A-5]",Supporting & Related Material,Publication - Copyrighted Materials,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:01Z,,0,0,0900006483d7e6c8
EPA-HQ-OAR-2002-0095-0038,EPA,EPA-HQ-OAR-2002-0095,"J. A. Nusser, Senior Director, Environmental Compliance and Projects, Schering-Plough Corporation, Kenilworth, NJ [A-93-39-IX-A-6]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:47:05Z,,0,0,0900006483d7e6c9
EPA-HQ-OAR-2002-0095-0033,EPA,EPA-HQ-OAR-2002-0095,"Minutes of the Teleconference with the Food & Drug Administration, Environmental Protection Agency, & Medisol Pharmaceuticals on 05-22-00 [A-93-39-VII-E-3]",Supporting & Related Material,Memorandum,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:47Z,,0,0,0900006483d7e6ce
EPA-HQ-OAR-2002-0095-0037,EPA,EPA-HQ-OAR-2002-0095,"J. F. Devaney, Aventis Pharma, Washington, D. C. [A-93-39-IX-A-7]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:47:01Z,,0,0,0900006483d7e6ca
EPA-HQ-OAR-2002-0095-0026,EPA,EPA-HQ-OAR-2002-0095,"S. D. Taylor, Assistant Director, Environment, BP Exploration (Alaska) Inc.; J. Hegna, Director, Regulatory Affairs, Phillips Alaska, Inc.; W. Jim Sweeney, Corp. Environmental Director, CHQ Support Services, Alyeska Pipeline Service Company, Anchorage, AK [A-93-39-IX-A-1]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:45:23Z,,0,0,0900006483d7e6c5
EPA-HQ-OAR-2002-0095-0032,EPA,EPA-HQ-OAR-2002-0095,"D. Hufford, Director, Strataspheric Protection Division, USEPA, responding to comments submitted by 3M Drug Delivery Systems (see VII-D- 01) [A-93-39-VII-H-1]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:44Z,,0,0,0900006483d7e6cf
EPA-HQ-OAR-2002-0095-0022,EPA,EPA-HQ-OAR-2002-0095,"J. E. Henney, M.D., Commissioner, Department of Health & Human Services, Food & Drug Administration, to supplement 03-06-00 letter [A-93-39-VII-H-7]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:09:04Z,,0,0,0900006483d7e6d6
EPA-HQ-OAR-2002-0095-0021,EPA,EPA-HQ-OAR-2002-0095,"Decision XI/14 from the Report on the Eleventh Meeting of the Parties, to the Montreal Protocol [A-93-39-VIII-B-1]",Supporting & Related Material,Report,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:09:02Z,,0,0,0900006483d7e6d7
EPA-HQ-OAR-2002-0095-0040,EPA,EPA-HQ-OAR-2002-0095,"D. Hufford, Director, Stratospheric Protection Division, USEPA, requesting
assistance from the Food & Drug Administration [A-93-39-VII-H-3]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:47:36Z,,0,0,0900006483d7e6d1
EPA-HQ-OAR-2002-0095-0030,EPA,EPA-HQ-OAR-2002-0095,"J. E. Henney, M.D., Commissioner, Department of Health & Human Services, Food & Drug Administration, to supplement 05-05-00 letter [A-93-39-VII-H-6]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:46:17Z,,0,0,0900006483d7e6d5
EPA-HQ-OAR-2002-0095-0025,EPA,EPA-HQ-OAR-2002-0095,"C. J. Morris and M. D. Woolf, Piper & Marbury L.L.P., Washington, DC on behalf of Aeropharm Technology, Inc., Edison, NJ. Application of Aeropharm Technology, Inc. For an Essential Use Exemption to the Phase-Out of Ozone-Depleting Substances.  [A-93-39-II-A-1]",Supporting & Related Material,Report,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:45:16Z,,0,0,0900006483d7eb6d
EPA-HQ-OAR-2002-0095-0019,EPA,EPA-HQ-OAR-2002-0095,"Letter from Paul Stolpman, Director, Office of Atmospheric Programs, EPA to essential Letter to Janet Woodcock M. D., Director of the Center for Drug Evaluation and Research, FDA requesting consultation on necessary CFCs for 2001 [A-93-39-VIII-B-3]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:08:14Z,,0,0,0900006483d7e6d9
EPA-HQ-OAR-2002-0095-0028,EPA,EPA-HQ-OAR-2002-0095,"P. Blenkinsop, IPAC Secretariat, International Pharmaceutical Aerosol Consortium (IPAC), Washington, D. C. [A-93-39-IX-A-3]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:45:48Z,,0,0,0900006483d7e6c7
EPA-HQ-OAR-2002-0095-0039,EPA,EPA-HQ-OAR-2002-0095,"T. Land, Stratospheric Protection Division, USEPA, responding to comments submitted by General Electric Company (see X-D-05) [A-93-39-VII-H-2]",Supporting & Related Material,Letter,2022-06-30T04:00:00Z,2022,6,,,2022-07-01T03:47:30Z,,0,0,0900006483d7e6d0
EPA-HQ-OAR-2002-0095-0016,EPA,EPA-HQ-OAR-2002-0095,Legacy Index for Docket A-93-39,Supporting & Related Material,Index,2019-08-14T04:00:00Z,2019,8,,,2019-08-14T18:59:12Z,,0,0,0900006483d7e22c
EPA-HQ-OAR-2002-0095-0003,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-1997-10-02
Request for Applications for Essential Use Exemptions to the Production and Import Phaseout of Ozone Depleting Substances Under the Montreal Protocol",Notice,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:10:20Z,97-26183,0,0,0900006483d7e1e7
EPA-HQ-OAR-2002-0095-0012,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2001-11-06
Request for Applications for Essential Use Exemptions to the Production and Import Phaseout of Ozone Depleting Substances under the Montreal Protocol for the years 2003 and 2004",Notice,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:49:36Z,01-27839,0,0,0900006483d7e203
EPA-HQ-OAR-2002-0095-0011,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2001-11-01
Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2002; and Extension of the De Minimis Exemption for Essential Laboratory and Analytical Uses through Calendar Year 2005",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,2001-12-04T04:59:59Z,2019-07-11T15:45:47Z,01-27383,0,0,0900006483d7e202
EPA-HQ-OAR-2002-0095-0010,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2001-03-13
Protection of the Stratospheric Ozone: De Minimis Exemption for Laboratory Essential Uses for Calendar Year 2001",Rule,Direct Final Rule,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:40:15Z,01-6084,0,0,0900006483d7e201
EPA-HQ-OAR-2002-0095-0005,EPA,EPA-HQ-OAR-2002-0095,A-93-39-F-R-1999-09-15,Notice,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:18:19Z,99-24046,0,0,0900006483d7e1e9
EPA-HQ-OAR-2002-0095-0004,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-1998-08-10
Request for Applications for Essential Use Exemptions to the Production and Import Phaseout of Ozone Depleting Substances Under the Montreal Protocol",Notice,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:12:02Z,98-21346,0,0,0900006483d7e1e8
EPA-HQ-OAR-2002-0095-0002,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-1996-09-30
Request for Applications for Essential Use Exemptions to the Production and Import Phaseout of Ozone Depleting Substances Under the Montreal Protocol",Notice,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2023-09-09T20:07:43Z,96-25001,0,0,0900006483d7e1e6
EPA-HQ-OAR-2002-0095-0007,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2000-10-06
Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2001",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,2000-11-07T04:59:59Z,2019-07-11T15:28:38Z,00-25745,0,0,0900006483d7e1eb
EPA-HQ-OAR-2002-0095-0015,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2002-11-06
Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2003",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,2002-12-07T04:59:59Z,2019-07-11T16:01:19Z,02-28212,0,0,0900006483d7e206
EPA-HQ-OAR-2002-0095-0009,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2001-01-08
Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2001: Allocation for Metered Dose Inhalers and the Space Shuttle and Titan Rockets",Rule,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:36:00Z,01-463,0,0,0900006483d7e200
EPA-HQ-OAR-2002-0095-0006,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2000-06-30
Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2000: Allocations for Metered-Dose Inhalers and the Space Shuttle and Titan Rockets",Rule,Final Rule,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:22:43Z,00-16628,0,0,0900006483d7e1ea
EPA-HQ-OAR-2002-0095-0013,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2002-02-11
Protection of Stratospheric Ozone: Allocation of Essential-use Allowances for Calendar Year 2002; and Extension of the De Minimis Exemption for Essential Laboratory and Analytical Uses through Calendar Year 2005",Rule,Final Rule,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:54:16Z,02-3101,0,0,0900006483d7e204
EPA-HQ-OAR-2002-0095-0008,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2000-11-01
Request for Applications for Essential Use Exemptions to the Production and Import Phaseout ef Ozone Depleting Substances Under the Montreal Protocol for the Years 2002 and 2003",Notice,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:32:08Z,00-28009,0,0,0900006483d7e1ff
EPA-HQ-OAR-2002-0095-0014,EPA,EPA-HQ-OAR-2002-0095,"A-93-39-F-R-2002-10-30
Request for Applications for Essential Use Exemptions to the Production and Import Phaseout of Ozone Depleting Substances Under the Montreal Protocol for the Years 2004 and 2005",Notice,,2019-07-11T04:00:00Z,2019,7,2019-07-11T04:00:00Z,,2019-07-11T15:57:17Z,02-27623,0,0,0900006483d7e205
EPA-HQ-OAR-2002-0095-0001,EPA,EPA-HQ-OAR-2002-0095,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2003; Final Rule,Rule,Final Rule,2002-12-27T05:00:00Z,2002,12,,,2019-07-11T14:37:43Z,02–32719,0,0,09000064800bad24